1. Home
  2. WNEB vs ARMP Comparison

WNEB vs ARMP Comparison

Compare WNEB & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western New England Bancorp Inc.

WNEB

Western New England Bancorp Inc.

HOLD

Current Price

$14.61

Market Cap

264.8M

Sector

Finance

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$6.01

Market Cap

295.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WNEB
ARMP
Founded
1853
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
264.8M
295.5M
IPO Year
2001
1996

Fundamental Metrics

Financial Performance
Metric
WNEB
ARMP
Price
$14.61
$6.01
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$13.67
$15.00
AVG Volume (30 Days)
55.9K
169.4K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
2.00%
N/A
EPS Growth
33.93
N/A
EPS
0.24
N/A
Revenue
$44,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.25
N/A
P/E Ratio
$61.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.57
$2.14
52 Week High
$14.68
$14.98

Technical Indicators

Market Signals
Indicator
WNEB
ARMP
Relative Strength Index (RSI) 67.33 35.73
Support Level $12.09 $5.14
Resistance Level N/A $6.60
Average True Range (ATR) 0.43 0.74
MACD 0.10 -0.03
Stochastic Oscillator 94.56 3.71

Price Performance

Historical Comparison
WNEB
ARMP

About WNEB Western New England Bancorp Inc.

Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: